Source: International Congress 2019 – Biomarkers and beyond in idiopathic interstitial pneumonia
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
K. Yamaguchi (Hiroshima, Japan), H. Iwamoto (Hiroshima, Japan), S. Sakamoto (Hiroshima, Japan), Y. Horimasu (Hiroshima, Japan), T. Masuda (Hiroshima, Japan), S. Miyamoto (Hiroshima, Japan), T. Nakashima (Hiroshima, Japan), S. Ohshimo (Hiroshima, Japan), K. Fujitaka (Hiroshima, Japan), H. Hamada (Hiroshima, Japan), N. Hattori (Hiroshima, Japan). Serum high mobility group box 1 is associated with the onset and severity of acute exacerbation of idiopathic pulmonary fibrosis. 2250

Member's Comments

No comment yet.

Related content which might interest you: Relationship between chronic dyspnoea and indices of disease severity in idiopathic pulmonary fibrosis (IPF) Source: Eur Respir J 2001; 18: Suppl. 33, 150s Year: 2001 Effects of an acute exacerbation requiring hospitalisation (AE) on lung function, muscle force and serum IGF-I levels in male patients with chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2002; 20: Suppl. 38, 564s Year: 2002 High mobility group box protein 1 (HMGB1) production in highly vascularized alveolar lesions causes acute exacerbation in idiopathic pulmonary fibrosis Source: Annual Congress 2005 - Progresses in lung fibrosis Year: 2005 Active smoking negatively affects recovery of patients hospitalized due to acute exacerbation of chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2011 - Smoking rate: smoking cessation interventions Year: 2011 Acute exacerbation of idiopathic pulmonary fibrosis: frequency and clinical features Source: Eur Respir J 2006; 27: 143-150 Year: 2006 High interleukin-33 is associated with acute exacerbation in patients with chronic obstructive pulmonary disease Source: Virtual Congress 2020 – Prediction of outcomes in obstructive diseases Year: 2020 Clinical value of C-reactive protein in severe acute exacerbations of COPD Source: Annual Congress 2005 - COPD - acute exacerbations Year: 2005 Modified GAP stage as a predictor of acute exacerbation in idiopathic pulmonary fibrosis Source: International Congress 2018 – Consequences of idiopathic interstitial pneumonias Year: 2018 Weight gain during acute treatment of an initial pulmonary exacerbation is associated with a longer interval to the next exacerbation in adults with cystic fibrosis Source: ERJ Open Res, 3 (3) 00057-2017; 10.1183/23120541.00057-2017 Year: 2017 Relationship between CRP levels and the severity of COPD acute exacerbations among group D COPD patients. Source: Virtual Congress 2020 – COPD phenotypes Year: 2020 Study on the relation between serum complement (C3, C4) levels and acute exacerbations in patients with chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2008 - Biomarkers and disease assessment in COPD Year: 2008 Asymmetry in acute exacerbation of idiopathic pulmonary fibrosis Source: ERJ Open Res, 3 (2) 00036-2016; 10.1183/23120541.00036-2016 Year: 2017 Plasma levels of circulating cell-free DNA are increased in idiopathic pulmonary fibrosis but do not correlate with disease severity Source: International Congress 2019 – Biomarkers of idiopathic interstitial pneumonia Year: 2019 Comparison of serum osteopontin levels in patients with exacerbations and stable chronic obstructive pulmonary disease Source: Annual Congress 2012 - Cell biology, blood and sputum biomarkers in airway diseases Year: 2012 Is high level of IgE an additional problem in smoking patients with severe and very severe chronic obstructive pulmonary disease (COPD)? Source: Annual Congress 2012 - COPD: epidemiology and varia Year: 2012 Markers of pulmonary injury and inflammation are elevated in the serum of patients with chronic cough Source: Virtual Congress 2021 – Clinical features and new biomarkers of asthma, COPD and chronic cough Year: 2021 Vulnerability of fatal infection under steroid treatment in patients with idiopathic pulmonary fibrosis (IPF) Source: Eur Respir J 2002; 20: Suppl. 38, 354s Year: 2002 Late Breaking Abstract - Elevated growth differentiation factor 15 in serum correlated with acute exacerbation of idiopathic pulmonary fibrosis Source: International Congress 2019 – Idiopathic pulmonary fibrosis and surroundings Year: 2019 The safety of sputum induction in patients with exacerbation of severe and very severe COPD (chronic obstructive pulmonary disease) Source: Annual Congress 2008 - Organisation of care and management of COPD Year: 2008 Prevalence and impact of WHO group 3 pulmonary hypertension in advanced idiopathic nonspecific interstitial pneumonia Source: Eur Respir J, 52 (1) 1800545; 10.1183/13993003.00545-2018 Year: 2018